Late pop culture icon Jimmy Buffett is fueling a bitter court war, as wife Jane fights to upend his alleged final wishes and take full control of his $275 million estate. After suing co-trustee ...

I use 1Password, and I don’t pay for it. The company provides complimentary accounts to journalists, not for us to evaluate the product and write about it, but as part of a program aimed at helping ...

This may not apply in your husband’s case, but it’s worth having the conversation. The two meds Goldstein prescribes for men are flibanserin (Addyi), an oral tablet taken d ...

Abstract: Urological health is a global concern since urologic cancers that remain undiagnosed and untreated, mostly kidney, bladder, and prostate cancer, can lead to ghastly physical, psychological, ...

Increasing use of blood tests to detect prostate cancer is leading to overworked doctors. NTNU has now created an AI diagnostic tool that can help lighten the burden.

Increasing use of blood tests to detect prostate cancer is leading to overworked doctors. NTNU has now created an AI diagnostic tool that can help ...

Learn how Huntsman Cancer Institute uses cutting‑edge diagnostics and personalized care to treat early‑stage prostate cancer.

New research suggests that an existing blood test may help to determine when someone is likely to develop Alzheimer's disease ...

Dr Marc Laniado made a choice to be more mindful of his own health - here's what he discovered, from 'exercise snacking' to the value of pet friends ...

Experts discuss the cardiovascular risks associated with androgen deprivation therapy, comparing Relugolix and Leuprolide's impact on coronary plaque formation. How does real-world evidence on ...

Overall, serious adverse events occurred in 3.9% of patients over the 6-month study period. Use of relugolix among patients with prostate cancer is associated with stable quality of life (QoL), high ...

A phase 1/2, open-label, randomized, dose-finding and dose expansion study of gedatolisib in combination with darolutamide in metastatic castration-resistant prostate cancer (mCRPC). This is an ASCO ...